Considerable efforts have been made to tackle the cancer driver KRAS, a bona fide oncoprotein that lacks clearly druggable cavities or grooves, and a number of early studies concluded that KRAS-mutant tumors become addicted to autophagy. The gene discussed is KRAS; the disease is cancer.